MichaelMorseMDMHS, FACP

Clinical Trials

• QUILT-3.019: Phase 2 Study of NPC-1C Chimeric Monoclonal Antibody to Treat Pancreatic and Colorectal Cancer Start of enrollment: 2012 Jan 01

  Completed

  Phase 1, Phase 2

• A Phase I Safety Study of a Cancer Vaccine to Treat HLA-A2 Positive Advanced Stage Ovarian, Breast and Prostate Cancer Start of enrollment: 2010 Mar 01

  Completed

  Phase 1

• Active Immunotherapy CEA Vaccine in Patients With Malignancies Expressing CEA Start of enrollment: 2010 Jun 01

  Completed

  Phase 1, Phase 2

• A Phase I Study To Evaluate The Antitumor Activity And Safety Of AVX901 Start of enrollment: 2012 Feb 01

  Completed

  Phase 1

• Immunotherapy With CEA(6D) VRP Vaccine (AVX701) in Patients With Stage III Colorectal Cancer Start of enrollment: 2013 Nov 01

  Completed

  Phase 1

• Safety and Efficacy of Combination Listeria/GVAX Pancreas Vaccine in the Pancreatic Cancer Setting Start of enrollment: 2014 Feb 05

  Completed

  Phase 2

• Pilot Study of Interferon Alfa for Patients Who Have Received Cancer Vaccines Start of enrollment: 2005 Nov 01

  Terminated

  Phase 2

• A Study of HS-196, an HSP90 Inhibitor-linked NIR Probe for Solid Malignancies Start of enrollment: 2018 Aug 10

  Terminated

  Phase 1

• Assessing the Immunogenicity of pING-hHER3FL Start of enrollment: 2020 Jul 13

  Recruiting

  Phase 1

• HS-201, an HSP90 Inhibitor-linked Verteporfin for Detection of Solid Malignancies Start of enrollment: 2020 Jul 15

  Withdrawn

  Phase 1

• Lutetium 177Lu-Edotreotide Versus Best Standard of Care in Well-differentiated Aggressive Grade-2 and Grade-3 GastroEnteroPancreatic NeuroEndocrine Tumors (GEP-NETs) - COMPOSE Start of enrollment: 2021 Dec 21

  Recruiting

  Phase 3

  Roles: Contact

• Join now to see all